Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenalytix Plc Share News (RENX)

Share Price Information for Renalytix Plc (RENX)

Share Price is delayed by 15 minutes
Get Live Data
1.80    0.00 (0.00%)
Bid:
1.60
Ask:
2.00
Spread: 0.40 (25.00%)
Market Cap: £7.87m
RENX Live PriceLast checked at - London Stock Exchange

Intraday Renalytix Plc Share Chart

Renalytix Plc News

Renalytix anticipates meeting expectations as test sales grow slightly
27 Jan 2025

Renalytix anticipates meeting expectations as test sales grow slightly

(Alliance News) - Renalytix PLC on Monday said it is on track to meet financial expectations for financial 2025 and 2026 and it expects to report a sl...

Renalytix says confident to deliver on annual revenue target
20 Dec 2024

Renalytix says confident to deliver on annual revenue target

(Alliance News) - Renalytix PLC on Thursday said its new commercial strategy is working and that it is delivering growth from its Direct-to-Doctor sal...

Renalytix rises amid well supported fund raise; narrowed annual loss
1 Oct 2024

Renalytix rises amid well supported fund raise; narrowed annual loss

(Alliance News) - Renalytix PLC on Tuesday announced a successful fund raise alongside a narrowed annual loss.

LONDON MARKET CLOSE: Oil price hurts FTSE and investors dial out of BT
20 Aug 2024

LONDON MARKET CLOSE: Oil price hurts FTSE and investors dial out of BT

(Alliance News) - Falling oil prices which knocked share prices of index heavyweights, BP and Shell, plus a sharp drop in BT, weighed on London's blue...

IN BRIEF: Renalytix ends sale process without offer; considers funding
20 Aug 2024

IN BRIEF: Renalytix ends sale process without offer; considers funding

Renalytix PLC - London-based in vitro diagnostics for kidney disease - Shares fall as Renalytix ends the formal sale process it launched back in March...

Renalytix terminates formal sale process
20 Aug 2024

Renalytix terminates formal sale process

(Sharecast News) - Renalytix, a company specialising in artificial intelligence-enabled diagnostics for kidney disease, announced the termination of i...